Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
RET C634W
i
Other names:
RET, Ret Proto-Oncogene, Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret, Cadherin-Related Family Member 16, Rearranged During Transfection, RET Receptor Tyrosine Kinase, Cadherin Family Member 12, Proto-Oncogene C-Ret, CDHF12, CDHR16, PTC, Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease), Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease 1, RET-ELE1, HSCR1, MEN2A, MEN2B, RET51, MTC1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5979
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
x
x
x
x
Reset Filters
RET C634W
Thyroid Gland Medullary Carcinoma
RET C634W
Thyroid Gland Medullary Carcinoma
TAS0953/HM06
Sensitive: D – Preclinical
Nat Cancer - 1 week (New D)
TAS0953 / HM06
Sensitive
:
D
Nat Cancer - 1wk
TAS0953/HM06
Sensitive: D – Preclinical
Nat Cancer - 1 week
TAS0953 / HM06
Sensitive
:
D
Nat Cancer - 1 week - (New D)
RET C634W
Thyroid Gland Carcinoma
RET C634W
Thyroid Gland Carcinoma
regorafenib
Sensitive: D – Preclinical
regorafenib
Sensitive
:
D
regorafenib
Sensitive: D – Preclinical
regorafenib
Sensitive
:
D
RET C634W
Thyroid Gland Medullary Carcinoma
RET C634W
Thyroid Gland Medullary Carcinoma
RAF265
Sensitive: D – Preclinical
RAF265
Sensitive
:
D
RAF265
Sensitive: D – Preclinical
RAF265
Sensitive
:
D
RET C634W
Thyroid Gland Medullary Carcinoma
RET C634W
Thyroid Gland Medullary Carcinoma
AMG 706
Resistant: D – Preclinical
AMG 706
Resistant
:
D
AMG 706
Resistant: D – Preclinical
AMG 706
Resistant
:
D
RET C634W
Thyroid Gland Medullary Carcinoma
RET C634W
Thyroid Gland Medullary Carcinoma
lenvatinib
Sensitive: D – Preclinical
lenvatinib
Sensitive
:
D
lenvatinib
Sensitive: D – Preclinical
lenvatinib
Sensitive
:
D
RET C634W
Thyroid Gland Carcinoma
RET C634W
Thyroid Gland Carcinoma
ponatinib
Sensitive: D – Preclinical
ponatinib
Sensitive
:
D
ponatinib
Sensitive: D – Preclinical
ponatinib
Sensitive
:
D
RET C634W
Thyroid Gland Medullary Carcinoma
RET C634W
Thyroid Gland Medullary Carcinoma
cabozantinib capsule
Sensitive: D – Preclinical
cabozantinib capsule
Sensitive
:
D
cabozantinib capsule
Sensitive: D – Preclinical
cabozantinib capsule
Sensitive
:
D
RET C634W
Thyroid Gland Papillary Carcinoma
RET C634W
Thyroid Gland Papillary Carcinoma
AZD1480
Sensitive: D – Preclinical
AZD1480
Sensitive
:
D
AZD1480
Sensitive: D – Preclinical
AZD1480
Sensitive
:
D
RET C634W
Thyroid Gland Carcinoma
RET C634W
Thyroid Gland Carcinoma
TY-1091
Sensitive: D – Preclinical
TY-1091
Sensitive
:
D
TY-1091
Sensitive: D – Preclinical
TY-1091
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login